The pharmacology of asthma and possible therapeutic developments.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D001249:Asthma / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D001792:Blood Platelets; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002449:Cell Aggregation; D003165:Complement System Proteins; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006632:Histamine / Q000494:pharmacology; D006636:Histamine Release; D006801:Humans; D007111:Immunity, Cellular; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007705:Kinins / Q000494:pharmacology; D007962:Leukocytes / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000378:metabolism; D008247:Lysosomes / Q000201:enzymology; D011817:Rabbits; D013189:SRS-A / Q000032:analysis
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D007074:Immunoglobulin G; D007705:Kinins; D013189:SRS-A; D007073:Immunoglobulin E; D006632:Histamine; D003165:Complement System Proteins; D004205:Cromolyn Sodium